Skip to main content
Friday
November 29, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
NOVEMBER 29, 2024
Covid Omicron Variant
Coronavirus chronicle
Variant-adapted Covid vaccine wins first approval in Britain
Coronavirus chronicle
AstraZeneca therapy works against omicron; results mixed for Regeneron
Coronavirus chronicle
Singapore mulls Covid-19 boosters requirement to qualify as 'fully' vaccinated
Coronavirus chronicle
Two-dose vaccines induce lower antibodies against Omicron, study finds
Coronavirus chronicle
WHO's Tedros says omicron coronavirus variant highlights ‘perilous situation’
Coronavirus chronicle
EU agency says Omicron cases so far appear 'mostly mild'. Then cautions
Coronavirus chronicle
Omicron is a wake-up call for Covid-19 vaccine developers
Coronavirus chronicle
New data shows GSK-Vir drug works against all Omicron mutations
Coronavirus chronicle
Omicron vs delta: Battle of coronavirus mutants is critical
Coronavirus chronicle
Fourth case of Omicron Covid-19 variant detected in India
Analysis
Omicron is a result of inequity in vaccine distribution
Coronavirus chronicle
Australia records first Omicron community case, authorities hold nerve for now
Coronavirus chronicle
S Africa's health body sees threefold higher risk of reinfection from Omicron
Show More